K P Geer, M E Ropka, W F Cohn, S M Jones, S Miesfeldt. J Genet Couns 2001
Times Cited: 63
Times Cited: 63
Times Cited
Times Co-cited
Similarity
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
20
Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
19
Referral to cancer genetic counseling: are there stages of readiness?
Suzanne M O'Neill, June A Peters, Victor G Vogel, Eleanor Feingold, Wendy S Rubinstein. Am J Med Genet C Semin Med Genet 2006
Suzanne M O'Neill, June A Peters, Victor G Vogel, Eleanor Feingold, Wendy S Rubinstein. Am J Med Genet C Semin Med Genet 2006
30
Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Carla C Wárlám-Rodenhuis, Jan van den Bout, Margreet G E M Ausems. Genet Med 2007
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Carla C Wárlám-Rodenhuis, Jan van den Bout, Margreet G E M Ausems. Genet Med 2007
22
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
14
Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
14
Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
12
Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
12
12
Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.
Emily A Peterson, Kara J Milliron, Karen E Lewis, Susan D Goold, Sofia D Merajver. Cancer Epidemiol Biomarkers Prev 2002
Emily A Peterson, Kara J Milliron, Karen E Lewis, Susan D Goold, Sofia D Merajver. Cancer Epidemiol Biomarkers Prev 2002
12
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
12
Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer.
Donald W Hadley, Jean Jenkins, Eileen Dimond, Kenneth Nakahara, Liam Grogan, David J Liewehr, Seth M Steinberg, Ilan Kirsch. Arch Intern Med 2003
Donald W Hadley, Jean Jenkins, Eileen Dimond, Kenneth Nakahara, Liam Grogan, David J Liewehr, Seth M Steinberg, Ilan Kirsch. Arch Intern Med 2003
12
Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
Susan T Vadaparampil, Gwendolyn P Quinn, Cheryl A Miree, Jennifer Brzosowicz, Bradford Carter, Christine Laronga. Ann Surg Oncol 2009
Susan T Vadaparampil, Gwendolyn P Quinn, Cheryl A Miree, Jennifer Brzosowicz, Bradford Carter, Christine Laronga. Ann Surg Oncol 2009
29
Human genetics. Before it's too late--addressing fear of genetic information.
Karen H Rothenberg, Sharon F Terry. Science 2002
Karen H Rothenberg, Sharon F Terry. Science 2002
21
Discrimination as a consequence of genetic testing.
P R Billings, M A Kohn, M de Cuevas, J Beckwith, J S Alper, M R Natowicz. Am J Hum Genet 1992
P R Billings, M A Kohn, M de Cuevas, J Beckwith, J S Alper, M R Natowicz. Am J Hum Genet 1992
11
Why do women attend familial breast cancer clinics?
K Brain, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper. J Med Genet 2000
K Brain, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper. J Med Genet 2000
11
Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
11
Increasing utilization of cancer genetic counseling services using a patient navigator model.
Alanna Kulchak Rahm, Anna Sukhanova, Jennifer Ellis, Judy Mouchawar. J Genet Couns 2007
Alanna Kulchak Rahm, Anna Sukhanova, Jennifer Ellis, Judy Mouchawar. J Genet Couns 2007
17
The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
9
Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
9
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
9
Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination.
Katrina Armstrong, Barbara Weber, Genevieve FitzGerald, John C Hershey, Mark V Pauly, Jean Lemaire, Krupa Subramanian, David A Asch. Am J Med Genet A 2003
Katrina Armstrong, Barbara Weber, Genevieve FitzGerald, John C Hershey, Mark V Pauly, Jean Lemaire, Krupa Subramanian, David A Asch. Am J Med Genet A 2003
12
What do women really want to know? Motives for attending familial breast cancer clinics.
C J Van Asperen, S Van Dijk, M W Zoeteweij, D R M Timmermans, G H De Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, W Otten. J Med Genet 2002
C J Van Asperen, S Van Dijk, M W Zoeteweij, D R M Timmermans, G H De Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, W Otten. J Med Genet 2002
11
Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
9
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
9
Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
9
Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.
Béatrice Godard, Annabelle Pratte, Martine Dumont, Adèle Simard-Lebrun, Jacques Simard. Genet Test 2007
Béatrice Godard, Annabelle Pratte, Martine Dumont, Adèle Simard-Lebrun, Jacques Simard. Genet Test 2007
18
Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.
Sue V Petzel, Rachel Isaksson Vogel, Tracy Bensend, Anna Leininger, Peter A Argenta, Melissa A Geller. J Genet Couns 2013
Sue V Petzel, Rachel Isaksson Vogel, Tracy Bensend, Anna Leininger, Peter A Argenta, Melissa A Geller. J Genet Couns 2013
20
Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
Alyssa Kne, Heather Zierhut, Shari Baldinger, Karen K Swenson, Pamela Mink, Patricia McCarthy Veach, Michaela L Tsai. J Genet Couns 2017
Alyssa Kne, Heather Zierhut, Shari Baldinger, Karen K Swenson, Pamela Mink, Patricia McCarthy Veach, Michaela L Tsai. J Genet Couns 2017
22
Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
7
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
C Lerman, C Hughes, S J Lemon, D Main, C Snyder, C Durham, S Narod, H T Lynch. J Clin Oncol 1998
C Lerman, C Hughes, S J Lemon, D Main, C Snyder, C Durham, S Narod, H T Lynch. J Clin Oncol 1998
7
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
7
Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
7
Patients' fear of genetic discrimination by health insurers: the impact of legal protections.
M A Hall, S S Rich. Genet Med 2000
M A Hall, S S Rich. Genet Med 2000
9
Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
7
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
7
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
. J Clin Oncol 2003
. J Clin Oncol 2003
7
Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences.
Arwen H Pieterse, Margreet G E M Ausems, Alexandra M Van Dulmen, Frits A Beemer, Jozien M Bensing. Am J Med Genet A 2005
Arwen H Pieterse, Margreet G E M Ausems, Alexandra M Van Dulmen, Frits A Beemer, Jozien M Bensing. Am J Med Genet A 2005
8
Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.
C Foster, D G R Evans, R Eeles, D Eccles, S Ashley, L Brooks, T Cole, J Cook, R Davidson, H Gregory,[...]. Genet Test 2004
C Foster, D G R Evans, R Eeles, D Eccles, S Ashley, L Brooks, T Cole, J Cook, R Davidson, H Gregory,[...]. Genet Test 2004
10
The role of financial factors in acceptance of clinical BRCA genetic testing.
Shannon Kieran, Lois J Loescher, Kyung Hee Lim. Genet Test 2007
Shannon Kieran, Lois J Loescher, Kyung Hee Lim. Genet Test 2007
15
Cancer genetics evaluation: barriers to and improvements for referral.
Rachael Brandt, Zonera Ali, Allison Sabel, Terri McHugh, Paul Gilman. Genet Test 2008
Rachael Brandt, Zonera Ali, Allison Sabel, Terri McHugh, Paul Gilman. Genet Test 2008
14
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
7
Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
6
Genetic testing in families with hereditary nonpolyposis colon cancer.
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
6
Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.
K A Phillips, E Warner, W S Meschino, J Hunter, M Abdolell, G Glendon, I L Andrulis, P J Goodwin. Clin Genet 2000
K A Phillips, E Warner, W S Meschino, J Hunter, M Abdolell, G Glendon, I L Andrulis, P J Goodwin. Clin Genet 2000
10
Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients.
Kira A Apse, Barbara B Biesecker, Francis M Giardiello, Barbara P Fuller, Barbara A Bernhardt. Genet Med 2004
Kira A Apse, Barbara B Biesecker, Francis M Giardiello, Barbara P Fuller, Barbara A Bernhardt. Genet Med 2004
9
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004
6
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
6
Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.
Jeffrey N Weitzel, Sarah M McCaffrey, Raluca Nedelcu, Deborah J MacDonald, Kathleen R Blazer, Carey A Cullinane. Arch Surg 2003
Jeffrey N Weitzel, Sarah M McCaffrey, Raluca Nedelcu, Deborah J MacDonald, Kathleen R Blazer, Carey A Cullinane. Arch Surg 2003
6
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.